Co-Authors
This is a "connection" page, showing publications co-authored by Laura Andreoli and Franco Franceschini.
Connection Strength
1.212
-
Coagulation dysfunction in COVID-19: The interplay between inflammation, viral infection and the coagulation system. Blood Rev. 2021 03; 46:100745.
Score: 0.225
-
Association between treatment with colchicine and improved survival in a single-centre cohort of adult hospitalised patients with COVID-19 pneumonia and acute respiratory distress syndrome. Ann Rheum Dis. 2020 10; 79(10):1286-1289.
Score: 0.224
-
The 2016 classification criteria for primary Sjogren's syndrome: what's new? BMC Med. 2017 03 31; 15(1):69.
Score: 0.178
-
Response to: 'Correspondence on 'Association between treatment with colchicine and improved survival in a single-centre cohort of adult hospitalised patients with COVID-19 pneumonia and acute respiratory distress syndrome'' by Kawada. Ann Rheum Dis. 2021 Jan 27.
Score: 0.058
-
Anti-Phospholipid Antibodies in COVID-19 Are Different From Those Detectable in the Anti-Phospholipid Syndrome. Front Immunol. 2020; 11:584241.
Score: 0.057
-
Why not to use colchicine in COVID-19? An oldanti-inflammatory drug for a novel auto-inflammatory disease. Rheumatology (Oxford). 2020 07 01; 59(7):1769-1770.
Score: 0.056
-
Laboratory considerations amidst the coronavirus disease 2019 outbreak: the Spedali Civili in Brescia experience. Bioanalysis. 2020 Sep; 12(17):1223-1230.
Score: 0.056
-
The rationale for the use of colchicine in COVID-19: comments on the letter by Cumhur Cure M et al. Clin Rheumatol. 2020 08; 39(8):2489-2490.
Score: 0.056
-
COVID-19 in patients with rheumatic diseases in northern Italy: a single-centre observational and case-control study. Lancet Rheumatol. 2020 Sep; 2(9):e549-e556.
Score: 0.055
-
Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy. Autoimmun Rev. 2020 Jul; 19(7):102568.
Score: 0.055
-
Association Between Changes in BLyS Levels and the Composition of B and T Cell Compartments in Patients With Refractory Systemic Lupus Erythematosus Treated With Belimumab. Front Pharmacol. 2019; 10:433.
Score: 0.051
-
First Report of the Italian Registry on Immune-Mediated Congenital Heart Block (Lu.Ne Registry). Front Cardiovasc Med. 2019; 6:11.
Score: 0.051
-
Update on Antiphospholipid Syndrome: Ten Topics in 2017. Curr Rheumatol Rep. 2018 03 15; 20(3):15.
Score: 0.047
-
Longterm Outcome of Patients with Primary Antiphospholipid Syndrome: A Retrospective Multicenter Study. J Rheumatol. 2017 08; 44(8):1165-1172.
Score: 0.045